LakeShore Biopharma's total assets for Q4 2024 were ¥1.51B, an increase of 0.15% from the previous quarter. LSB total liabilities were ¥927.82M for the fiscal quarter, a -10.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.